This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1996 Jul-Aug;62(4):270-1.

Systemic corticosteroids in toxic epidermal necrolysis

S Dhar¹

Affiliations

PMID: 20948085

Systemic corticosteroids in toxic epidermal necrolysis

S Dhar. Indian J Dermatol Venereol Leprol. 1996 Jul-Aug.

. 1996 Jul-Aug;62(4):270-1.

Author

S Dhar¹

Affiliation

¹ Kota, India.

PMID: 20948085

No abstract available

PubMed Disclaimer

Similar articles

Basic measures and systemic medical treatment of patients with toxic epidermal necrolysis.
Hanken I, Schimmer M, Sander CA. Hanken I, et al. J Dtsch Dermatol Ges. 2010 May;8(5):341-6. doi: 10.1111/j.1610-0387.2009.07289.x. Epub 2009 Oct 21. J Dtsch Dermatol Ges. 2010. PMID: 19845819 English, German.
A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
Arca E, Köse O, Erbil AH, Nişanci M, Akar A, Gür AR. Arca E, et al. Pediatr Dermatol. 2005 Jul-Aug;22(4):317-20. doi: 10.1111/j.1525-1470.2005.22407.x. Pediatr Dermatol. 2005. PMID: 16060867
Phenytoin-induced toxic epidermal necrolysis: a case report.
Creamer JD, Whittaker SJ, Kerr-Muir M, Smith NP. Creamer JD, et al. Clin Exp Dermatol. 1996 Mar;21(2):116-20. Clin Exp Dermatol. 1996. PMID: 8759197
Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
Letko E, Papaliodis DN, Papaliodis GN, Daoud YJ, Ahmed AR, Foster CS. Letko E, et al. Ann Allergy Asthma Immunol. 2005 Apr;94(4):419-36; quiz 436-8, 456. doi: 10.1016/S1081-1206(10)61112-X. Ann Allergy Asthma Immunol. 2005. PMID: 15875523 Review.
Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of treatment options.
Worswick S, Cotliar J. Worswick S, et al. Dermatol Ther. 2011 Mar-Apr;24(2):207-18. doi: 10.1111/j.1529-8019.2011.01396.x. Dermatol Ther. 2011. PMID: 21410610 Review.

See all similar articles

Cited by

Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome.
Jacobsen A, Olabi B, Langley A, Beecker J, Mutter E, Shelley A, Worley B, Ramsay T, Saavedra A, Parker R, Stewart F, Pardo Pardo J. Jacobsen A, et al. Cochrane Database Syst Rev. 2022 Mar 11;3(3):CD013130. doi: 10.1002/14651858.CD013130.pub2. Cochrane Database Syst Rev. 2022. PMID: 35274741 Free PMC article.
A six-month prospective study to find out the treatment outcome, prognosis and offending drugs in toxic epidermal necrolysis from an urban institution in kolkata.
Das S, Roy AK, Biswas I. Das S, et al. Indian J Dermatol. 2013 May;58(3):191-3. doi: 10.4103/0019-5154.110826. Indian J Dermatol. 2013. PMID: 23723468 Free PMC article.
Management of Stevens-Johnson Syndrome-Toxic Epidermal Necrolysis: Looking Beyond Guidelines!
Kumar R, Das A, Das S. Kumar R, et al. Indian J Dermatol. 2018 Mar-Apr;63(2):117-124. doi: 10.4103/ijd.IJD_583_17. Indian J Dermatol. 2018. PMID: 29692452 Free PMC article.

Publication types

Actions